Open AccessTime to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
Author(s) -
Giulia Sapuppo,
Martina Tavarelli,
Antonino Belfiore,
Riccardo Vigneri,
Gabriella Pellegriti
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01383
Subject(s) - medicine , disease , thyroid cancer , retrospective cohort study , cancer , gastroenterology
Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of patients with DTC have disease events after initial treatment, indistinctly defined as persistent/recurrent disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom